GlassScriptPhysician profile
Joseph Daniel Galloway
NPI 1821449604
$15,264.33
in general payments reported to CMS, 2019-2025
13 companies · $5,125 in 2025
The $5,125 reported for 2025 was more than what a typical Orthopaedic Trauma provider received nationally (typical 2025 total: $1,227).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,328 · 2020: $341 · 2021: $1,841 · 2022: $3,756 · 2023: $942 · 2024: $1,932 · 2025: $5,125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,066 · Food and Beverage: $2,934.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,065.50 |
| Food and Beverage | $2,933.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $8,796.98 | 2019-2025 | Pro, T2, T2 Alpha |
| Medical Device Business Services, INC. | $2,751.49 | 2019-2022 | |
| Depuy Synthes Sales INC. | $1,092.24 | 2019-2024 | Na, Tfn-Advance |
| Arthrex, INC. | $1,009.90 | 2025 | |
| Seapearl East, INC | $715.41 | 2025 | |
| Globus Medical, INC. | $288.50 | 2022-2025 | Autobahn, Anthem, Distal Femur Plate System |
| Smith+Nephew, INC. | $156.50 | 2022 | |
| Peerless Surgical INC. | $146.74 | 2022 | |
| Davol INC. | $126.62 | 2021 | |
| Integra Lifesciences Corporation | $111.95 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Heron Therapeutics, INC. | $29.00 | 2022 | |
| Ethicon US, LLC | $25.00 | 2025 | Vistaseal, Dermabond Prineo, Evarrest |
| Vertex Pharmaceuticals Incorporated | $14.00 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Galloway listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.